Literature DB >> 1350288

T-deficient transmembrane signaling in CD4+ T cells of retroviral-induced immune-deficient mice.

E A Fitzpatrick1, J S Bryson, C Rhoads, A M Kaplan, D A Cohen.   

Abstract

The defective virus found in the LP-BM5 mixture of murine leukemia viruses induces a severe immune deficiency disease in C57BL/6 mice that is characterized by the activation and expansion of T and B cells that become unresponsive to normal immune stimuli. The nature of the biochemical lesion in these defective lymphocyte populations remains unknown. Flow cytometric analysis of the T cell population in infected animals has demonstrated expansion of both CD4+ and CD8+ subsets. Despite chronic expansion in vivo, CD4+ T cells by wk 4 postinfection failed to up-regulate cell surface IL-2R expression, produced IL-2, or proliferate in vitro in response to either Con A, Staphylococcal enterotoxin super-antigens, or anti-CD3 stimulation. Exogenous IL-2 did not restore the proliferative response and also failed to up-regulate IL-R expression on CD4+ T cells from infected mice, even though basal IL-2R expression was initially elevated compared to normals. In contrast, CD4+ T cells from infected mice could be induced to proliferate by stimulation with PMA and ionomycin resulting in IL-2R up-regulation, IL-2 production, and proliferation. Moreover, proliferation could also be induced by anti-CD3 plus PMA, although anti-CD3 plus ionomycin was without effect. These studies suggest that chronic expansion of CD4+ T cells in infected mice is probably not maintained by normal TCR signaling, which appears defective in these cells. In addition, the lesion in biochemical signaling appears to result in defective activation of protein kinase C, which can be overcome by direct activation with PMA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350288

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Endogenous Mtv-encoded superantigens are not required for development of murine AIDS.

Authors:  T C McCarty; S K Chattopadhyay; M T Scherer; T N Fredrickson; J W Hartley; H C Morse
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 2.  Cells and cytokines in the pathogenesis of MAIDS, a retrovirus-induced immunodeficiency syndrome of mice.

Authors:  H C Morse; N Giese; R Morawetz; Y Tang; R Gazzinelli; W K Kim; S Chattopadhyay; J W Hartley
Journal:  Springer Semin Immunopathol       Date:  1995

3.  Studies of the susceptibility of nude, CD4 knockout, and SCID mutant mice to the disease induced by the murine AIDS defective virus.

Authors:  C Simard; S J Klein; T Mak; P Jolicoeur
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  The MA (p15) and p12 regions of the gag gene are sufficient for the pathogenicity of the murine AIDS virus.

Authors:  J M Pozsgay; M W Beilharz; B D Wines; A D Hess; P M Pitha
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

5.  Evidence that the murine AIDS defective virus does not encode a superantigen.

Authors:  L Doyon; C Simard; R P Sékaly; P Jolicoeur
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

6.  Dissociation between lymphoproliferative responses and virus replication in mice with different sensitivities to retrovirus-induced immunodeficiency.

Authors:  J M Pozsgay; S Reid; P M Pitha
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

7.  Modulation of murine AIDS-related pathology by concurrent antibody treatment and coinfection with Leishmania major.

Authors:  T M Doherty; N Giese; H C Morse; R L Coffman
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.